Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

Morganna Freeman-Keller, Young‐Chul Kim, Heather Cronin et al. · Clinical Cancer Research · 2015 · 875 citations · Full text

Medicine, Oncology, Pharmacology +17

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Lars Hofmann, Andrea Forschner, Carmen Loquai et al. · European Journal of Cancer · 2016 · 647 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Autoimmune pancreatitis: CT and MR characteristics.

H. Irie, Hidehiko Honda, Shingo Baba et al. · American Journal of Roentgenology · 1998 · 337 citations

Medicine, Internal Medicine, Pathology +16